FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

VistaPharm Nystatin Oral Suspension Recall

Nystatin Oral Suspension, USP 500,000 units/5mL Cup, Delivers 5 mL, Rx Only, Manufactu…

VistaPharm, Inc. · Largo, FL

Risk level
Class III
Reported by FDA
Jul 15, 2020
Recall ID
D-1377-2020
Check your lot numberHow we source this data

Summary

VistaPharm recalled Nystatin Oral Suspension starting Jun 23, 2020. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1377-2020 on Jul 15, 2020. Reason: Failed impurities/degradation products; Presence of an impurity peak that exceeds the approved specification. Status: Terminated.

Why it was recalled

Failed impurities/degradation products; Presence of an impurity peak that exceeds the approved specification.

Product description

Nystatin Oral Suspension, USP 500,000 units/5mL Cup, Delivers 5 mL, Rx Only, Manufactured by: VistaPharm, Largo, FL 33771, a) NDC 66689-037-50 (individual cup NDC: 66689-037-01); b) 66689-037-99.

Lot numbers, UPCs & expiration codes

Lot #: a) 619800, Exp. 12/31/2020; 626200, Exp. 01/31/2021; b) 619800X,Exp. 12/31/2020; 626200X, Exp. 01/31/2021.

Where it was sold

United States including Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1377-2020
Classification
Class III
Status
Terminated
Recall initiated
Jun 23, 2020
FDA report date
Jul 15, 2020
Quantity
380,700 cups
Recall type
Voluntary: Firm initiated
Recalling firm
VistaPharm, Inc.

Original FDA data

Every field from FDA enforcement report D-1377-2020, exactly as published.

Show all FDA fields
City
Largo
State
FL
Status
Terminated
Country
United States
Event ID
85888
Address
7265 Ulmerton Rd
Code information
Lot #: a) 619800, Exp. 12/31/2020; 626200, Exp. 01/31/2021; b) 619800X,Exp. 12/31/2020; 626200X, Exp. 01/31/2021.
Postal code
33771-4809
Report date
Jul 15, 2020
Product type
Drugs
Recall number
D-1377-2020
Classification
Class III
Recalling firm
VistaPharm, Inc.
Product quantity
380,700 cups
Termination date
Sep 28, 2022
Reason for recall
Failed impurities/degradation products; Presence of an impurity peak that exceeds the approved specification.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Nystatin Oral Suspension, USP 500,000 units/5mL Cup, Delivers 5 mL, Rx Only, Manufactured by: VistaPharm, Largo, FL 33771, a) NDC 66689-037-50 (individual cup NDC: 66689-037-01); b) 66689-037-99.
Distribution pattern
United States including Puerto Rico
Recall initiation date
Jun 23, 2020
Initial firm notification
Letter
Center classification date
Jul 8, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1377-2020, published Jul 15, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls